0001100441-17-000011.txt : 20170509
0001100441-17-000011.hdr.sgml : 20170509
20170509121502
ACCESSION NUMBER: 0001100441-17-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170505
FILED AS OF DATE: 20170509
DATE AS OF CHANGE: 20170509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RTI SURGICAL, INC.
CENTRAL INDEX KEY: 0001100441
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 593466543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11621 RESEARCH CIRCLE
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-418-8888
MAIL ADDRESS:
STREET 1: 11621 RESEARCH CIRCLE
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: RTI Biologics, Inc.
DATE OF NAME CHANGE: 20080227
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERATION TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STOLPER MARK
CENTRAL INDEX KEY: 0001281961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31271
FILM NUMBER: 17825391
MAIL ADDRESS:
STREET 1: 150 COTNER AVENUE
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-05-05
0
0001100441
RTI SURGICAL, INC.
RTIX
0001281961
STOLPER MARK
C/O RTI SURGICAL, INC.
11621 RESEARCH CIRCLE
ALACHUA
FL
32615
1
0
0
0
Common Stock
2017-05-05
4
P
0
5000
4.57
A
11331
D
Purchased on open market.
/s/Mark Stolper
2017-05-09
EX-24
2
poa_stolper.txt
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
The undersigned hereby makes, constitutes and appoints
each of Robert Jordheim and Emil Koller as the undersigned's
true and lawful attorney-in-fact, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of the
undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including
any amendments thereto) with respect to the securities of RTI Surgical, Inc.,
a Delaware corporation (the "Company"), with the United States Securities and
Exchange Commission, any national securities exchanges and the Company, as
considered necessary or advisable under Section 16(a) of the Securities Exchange
Act of 1934 and the rules and regulations promulgated thereunder, as amended
from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees,
and the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Limited Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in his or her discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Limited Power of Attorney will be in such form
and will contain such information and disclosure as such attorney-in-fact,
in his or her discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for
profit disgorgement under Section 16(b) of the Exchange Act; and
(4) this Limited Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act.
The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Limited Power of Attorney shall remain in full force and effect until
revoked by the undersigned in a signed writing delivered to such attorney-in-
fact or until the undersigned is no longer required to file Forms 3, 4, and 5
with regards to the undersigned's ownership of, or transaction in the Company's
securities.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 27th day of March, 2017.
/s/ Mark D. Stolper
Signature
Mark D. Stolper
Print Name